<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851433</url>
  </required_header>
  <id_info>
    <org_study_id>JAUDON-FAIVRE 2014</org_study_id>
    <nct_id>NCT02851433</nct_id>
  </id_info>
  <brief_title>Evaluate the Protective Effect of Conditioning With Sevoflurane on the Myocardium</brief_title>
  <acronym>SUPRA</acronym>
  <official_title>Evaluate the Protective Effect of Conditioning With Sevoflurane Versus Propofol on the Myocardium in Scheduled Aortic Valve Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Heart surgery is a considerable source of stress for the myocardium that must be minimized.&#xD;
&#xD;
      Troponin Ic is a reliable marker to determine the level of this myocardial stress.&#xD;
&#xD;
      Studies have shown that post-conditioning with AVH has a protective effect on the myocardium,&#xD;
      if the treatment is initiated at the start of the ischemia.&#xD;
&#xD;
      The aim of this study is to evaluate the protective effect on the myocardium (by measuring&#xD;
      troponin levels) of the association of pre-conditioning and post-conditioning with&#xD;
      Sevoflurane (AVH) sedation administered during and after scheduled surgery for valve&#xD;
      replacement, via sternotomy or thoracotomy compared with total intravenous anaesthesia with&#xD;
      Propofol.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 14, 2015</start_date>
  <completion_date type="Actual">September 4, 2017</completion_date>
  <primary_completion_date type="Actual">August 29, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of troponin</measure>
    <time_frame>Change at Hour 6, Hour 12, Hour 24, Hour 48 compared with baseline level</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Sevoflurane Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total anaesthesia and postoperative inhaled sedation with Sevoflurane</intervention_name>
    <arm_group_label>Sevoflurane Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total intravenous anaesthesia with Propofol.</intervention_name>
    <arm_group_label>Propofol Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have provided informed written consent.&#xD;
&#xD;
          -  Aortic valve replacement via sternotomy or thoracotomy, under Cardiopulmonary bypass&#xD;
             (CPB).&#xD;
&#xD;
          -  Anterograde cardioplegia with cold blood&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults under guardianship.&#xD;
&#xD;
          -  Patients without national health insurance cover.&#xD;
&#xD;
          -  Epileptics.&#xD;
&#xD;
          -  Heart grafted patients.&#xD;
&#xD;
          -  Patients under 18 years and pregnant or beast-feeding women.&#xD;
&#xD;
          -  Aortic dissections and vascular surgery.&#xD;
&#xD;
          -  Contra-indications to treatment with Sevoflurane: hypersensitivity to halogen-based&#xD;
             anaesthetic agents, myopathy, personal or family history of malignant hyperthermia,&#xD;
             hyper-eosinophilia, liver disease, icterus or unexplained fever after anaesthesia with&#xD;
             a halogen-based anaesthetic agent&#xD;
&#xD;
          -  Contra-indications to treatment with Propofol: known hypersensitivity to propofol or&#xD;
             one of the constituents of the specific form used, hypersensitivity to peanuts or&#xD;
             soja.&#xD;
&#xD;
          -  pre-operative LVEF&lt;35%.&#xD;
&#xD;
          -  Coronary artery bypass graft alone or associated.&#xD;
&#xD;
          -  Mitral valve replacements.&#xD;
&#xD;
          -  Warm cardioplegia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2016</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

